Webinars, Workshops, and Summits

Find webinars, workshops, and summits that help medication-assisted treatment (MAT) professionals assess and manage the risks of administering medications to treat substance misuse.

Webinars, workshops, and summits are helpful resources for learning more about a topic. They may also help you maintain certification or licensure through continuing education (CE). These online courses and workshop materials are intended for a wide range of medication-assisted treatment (MAT) professionals, including lay persons who care for clients in a variety of settings.

If you are a treating physician, learn more about SAMHSA-supported opioid prescribing courses and buprenorphine training courses.

SAMHSA’s CE Efforts

The SAMHSA Center for Substance Abuse Treatment (CSAT) offers online CE courses for opioid treatment professionals through the SAMHSA Knowledge Application Program (KAP). These courses cover a variety of issues, including those related to MAT. Note that you will need to register for a free account before you can access the online courses.

Providing MAT Through Medication Units

A medication unit is a facility that is geographically separated from where an opioid treatment program (OTP) is headquartered.

MAT professionals can administer medications, collect samples, and conduct drug testing and analysis from medication units. However, admission services and addiction counseling cannot be conducted from within these facilities.

SAMHSA held a webinar in 2014 that included a series of presentations on regulations applying to medication units and case studies:

Buprenorphine Summits

CSAT, in partnership with the National Institute on Drug Abuse (NIDA), convened the 2014 Buprenorphine Summit to gather the perspectives of leaders from the field regarding the state of practice and their assessment of possible strategies for the future.

Participants during the event explored what is known about the adoption of buprenorphine to treat opioid use disorders, reasons why it has not been as widely prescribed as might have been expected, and ways that federal agencies, medical professionals, and consumers might enable buprenorphine treatment to become more accessible.

Access the 2014 Buprenorphine Summit Report of Proceedings (PDF | 2.96 MB) to learn more.

Additional Resources

The following are SAMHSA-supported webinars for MAT services providers, including treating physicians (some webinars may require registration):

The Division of Pharmacologic Therapies (DPT), part of CSAT, also provides buprenorphine training for physicians.

In addition, the Addiction Technology Transfer Center (ATTC) Network (funded by SAMHSA) has a training and events calendar to help you stay abreast of live webinars and workshops happening in the future.


The views expressed in these courses and related materials do not necessarily reflect the official policies of the Department of Health and Human Services (HHS); nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


SAMHSA-supported courses are planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship with the host organizations and CSAT.

Last Updated: 07/10/2019